financetom
Business
financetom
/
Business
/
Madrigal Pharmaceuticals Reports Preliminary Q4 Rezdiffra Net Sales of Up to $103 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Madrigal Pharmaceuticals Reports Preliminary Q4 Rezdiffra Net Sales of Up to $103 Million
Jan 13, 2025 5:44 AM

08:26 AM EST, 01/13/2025 (MT Newswires) -- Madrigal Pharmaceuticals ( MDGL ) on Monday reported preliminary Q4 Rezdiffra net sales of $100 million to $103 million.

The company also reported preliminary yearend 2024 cash, cash equivalents, restricted cash and marketable securities of about $931 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved